Stryker Corporation is a leading medical technology company that specializes in designing, manufacturing, and marketing innovative products and services for healthcare professionals and patients. The company offers a diverse range of medical devices, including surgical equipment, orthopedic implants, neurotechnology, and surgery assistance products. Stryker focuses on advancing healthcare through cutting-edge technology and solutions that enhance patient care, improve surgical outcomes, and streamline hospital operations. With a commitment to innovation and quality, Stryker plays a pivotal role in the medical industry, helping healthcare providers deliver effective treatment and improve the quality of life for patients around the world. Read More
For the past two years, the U.S. healthcare sector has been the forgotten stepchild of the equity markets. As the S&P 500 (SPX) surged on the back of an artificial intelligence gold rush and a resilient tech economy, healthcare investors were left nursing a "double-digit hangover." In 2024,
As the 44th Annual J.P. Morgan Healthcare Conference kicked off this week in San Francisco, all eyes turned to UnitedHealth Group (NYSE:UNH), the diversified healthcare giant that serves as the primary barometer for the multi-trillion-dollar U.S. medical sector. On January 12, 2026, the company issued a critical
Date: January 9, 2026 Introduction As the global healthcare landscape undergoes a seismic shift toward personalized medicine and AI-integrated care, Medtronic plc (NYSE: MDT) stands at a critical juncture. Once viewed as a reliable but sluggish dividend aristocrat, the world’s largest standalone medical technology firm has spent the last 24 months aggressively shedding its "legacy" [...]
Rock-bottom prices don't always mean rock-bottom businesses.
The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value trap?
Shares of medical technology company Stryker (NYSE:SYK) jumped 4.1% in the afternoon session after analyst firm Raymond James upgraded the stock to "Outperform" from "Market Perform" and set a $418 price target.
As the first week of 2026 draws to a close, a distinct shift in market leadership has become the defining story for Wall Street. After a multi-year period where technology and artificial intelligence infrastructure captured the lion's share of investor attention, the healthcare sector has emerged as the unexpected powerhouse
As of December 26, 2025, Baxter International Inc. (NYSE: BAX) stands at a pivotal crossroads in its nearly century-long history. Long considered a defensive "blue-chip" staple of the healthcare sector, Baxter spent much of the early 2020s grappling with the massive debt from its $10.5 billion acquisition of Hillrom, supply chain fragilities exposed by the [...]
Portage, Michigan, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its fourth quarter and full year 2025 on Thursday, January 29, 2026. A press release will be issued at approximately 4:05 p.m. ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company’s fourth quarter and full year that ended December 31, 2025.
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors.
However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.
New York, NY – December 17, 2025 – The Dow Jones Industrial Average (DJIA) has concluded December 2025 with a notable ascent, marking a period of robust performance that has seen the index reach new all-time record highs. This upward momentum, however, unfolds against a complex and often contradictory economic landscape, characterized
Despite recent pockets of volatility and "slips" in the U.S. stock market during late 2025, a robust corporate profit outlook is emerging as a powerful counter-narrative, fueling investor optimism and suggesting that still-higher prices for American equities may be on the horizon. While the Cboe Volatility Index (VIX) saw
December 11, 2025 – The U.S. stock market is currently witnessing a striking and arguably unprecedented divergence, as the Dow Jones Industrial Average (DJIA) continues its ascent to record highs, while the tech-heavy Nasdaq Composite grapples with a significant slump. This "Great Divergence" signals a profound recalibration of investor sentiment,
Portage, Michigan, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable January 30, 2026, to shareholders of record at the close of business on December 31, 2025, representing an increase of 4.8% versus the prior year and previous quarter.
Over the past six months, Stryker’s shares (currently trading at $350.50) have posted a disappointing 9% loss, well below the S&P 500’s 13.4% gain. This may have investors wondering how to approach the situation.
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Stryker (NYSE:SYK) and its peers.
